Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

1‐Aminoindan‐1,5‐dicarboxylic acid and (S)‐(+)‐2‐(3′‐carboxybicyclo(1.1.1) pentyl)‐glycine, two mGlu1 receptor‐preferring antagonists, reduce neuronal death in in vitro and in vivo models of cerebral ischaemia

1‐Aminoindan‐1,5‐dicarboxylic acid and (S)‐(+)‐2‐(3′‐carboxybicyclo(1.1.1) pentyl)‐glycine, two... Metabotropic glutamate (mGlu) receptors have been implicated in a number of physiological and pathological responses to glutamate, but the exact role of group I mGlu receptors in causing postischaemic injury is not yet clear. In this study, we examined whether the recently‐characterized and relatively selective mGlu1 receptor antagonists 1‐aminoindan‐1,5‐dicarboxylic acid (AIDA) and (S)‐(+)‐2‐(3′‐carboxybicyclo(1.1.1)pentyl)‐glycine (CBPG) could reduce neuronal death in vitro, following oxygen‐glucose deprivation (OGD) in murine cortical cell and rat organotypic hippocampal cultures, and in vivo, after global ischaemia in gerbils. When present in the incubation medium during the OGD insult and the subsequent 24 h recovery period, AIDA and CBPG significantly reduced neuronal death in vitro. The extent of protection was similar to that observed with the nonselective mGlu receptor antagonist (+)‐α‐methyl‐4‐carboxyphenylglycine ((+)MCPG) and with typical ionotropic glutamate (iGlu) receptor antagonists. Neuroprotection was also observed when AIDA or CBPG were added only after the OGD insult was terminated. Neuronal injury was not attenuated by the inactive isomer (–)MCPG, but was significantly enhanced by the nonselective mGlu receptor agonist (1S,3R)‐1‐aminocyclopentane‐1,3‐dicarboxylic acid ((1S,3R)‐ACPD) and the group I mGlu receptor agonist 3,5‐dihydroxyphenylglycine (3,5‐DHPG). The antagonists (+)MCPG, AIDA and CBPG were also neuroprotective in vivo, because i.c.v. administration reduced CA1 pyramidal cell degeneration examined 7 days following transient carotid occlusion in gerbils. Our results point to a role of mGlu1 receptors in the pathological mechanisms responsible for postischaemic neuronal death and propose a new target for neuroprotection. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Neuroscience Wiley

1‐Aminoindan‐1,5‐dicarboxylic acid and (S)‐(+)‐2‐(3′‐carboxybicyclo(1.1.1) pentyl)‐glycine, two mGlu1 receptor‐preferring antagonists, reduce neuronal death in in vitro and in vivo models of cerebral ischaemia

Download PDF
11 pages

Loading next page...
 
/lp/wiley/1-aminoindan-1-5-dicarboxylic-acid-and-s-2-3-carboxybicyclo-1-1-1-0ZKDJNdCxx

References (90)

Publisher
Wiley
Copyright
Copyright © 1999 Wiley Subscription Services, Inc., A Wiley Company
ISSN
0953-816X
eISSN
1460-9568
DOI
10.1046/j.1460-9568.1999.00786.x
Publisher site
See Article on Publisher Site

Abstract

Metabotropic glutamate (mGlu) receptors have been implicated in a number of physiological and pathological responses to glutamate, but the exact role of group I mGlu receptors in causing postischaemic injury is not yet clear. In this study, we examined whether the recently‐characterized and relatively selective mGlu1 receptor antagonists 1‐aminoindan‐1,5‐dicarboxylic acid (AIDA) and (S)‐(+)‐2‐(3′‐carboxybicyclo(1.1.1)pentyl)‐glycine (CBPG) could reduce neuronal death in vitro, following oxygen‐glucose deprivation (OGD) in murine cortical cell and rat organotypic hippocampal cultures, and in vivo, after global ischaemia in gerbils. When present in the incubation medium during the OGD insult and the subsequent 24 h recovery period, AIDA and CBPG significantly reduced neuronal death in vitro. The extent of protection was similar to that observed with the nonselective mGlu receptor antagonist (+)‐α‐methyl‐4‐carboxyphenylglycine ((+)MCPG) and with typical ionotropic glutamate (iGlu) receptor antagonists. Neuroprotection was also observed when AIDA or CBPG were added only after the OGD insult was terminated. Neuronal injury was not attenuated by the inactive isomer (–)MCPG, but was significantly enhanced by the nonselective mGlu receptor agonist (1S,3R)‐1‐aminocyclopentane‐1,3‐dicarboxylic acid ((1S,3R)‐ACPD) and the group I mGlu receptor agonist 3,5‐dihydroxyphenylglycine (3,5‐DHPG). The antagonists (+)MCPG, AIDA and CBPG were also neuroprotective in vivo, because i.c.v. administration reduced CA1 pyramidal cell degeneration examined 7 days following transient carotid occlusion in gerbils. Our results point to a role of mGlu1 receptors in the pathological mechanisms responsible for postischaemic neuronal death and propose a new target for neuroprotection.

Journal

European Journal of Neuroscience – Wiley

Published: Oct 1, 1999

There are no references for this article.